Labetuzumab Govitecan Biosimilar - Research Grade
Product Sizes
0.1 mg
£582.00
ICH5617G-0.1MG
1 mg
£2464.00
ICH5617G-1MG
About this Product
- SKU:
- ICH5617G
- Additional Names:
- SN38
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
- Immunogen:
- CEACAM5 / CEA / CD66e
- Isotype:
- IgG1
- Purity:
- >90%
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
